Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
City Line Behavioral Healthcare was a behavioral health holding company established in 2018 by Fulcrum Equity Partners to manage a portfolio of addiction treatment facilities. Headquartered in Yardley, Pennsylvania, the company operated through subsidiaries such as Life of Purpose Treatment Centers and Liberation Way, focusing on evidence-based and "reality-based" treatment for substance use disorders, particularly among young adults and adolescents. Its service offerings included a full continuum of care ranging from intensive outpatient programs to life-skills development and medication-assisted treatment. The company's operations were concentrated in the Mid-Atlantic and Southeastern United States, including a unique facility located on the campus of Florida Atlantic University. In April 2019, City Line Behavioral Healthcare and its subsidiaries filed for Chapter 7 bankruptcy following a high-profile investigation into fraudulent billing and kickback schemes associated with its predecessor management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on City Line Behavioral Healthcare.